TriSalus Life Sciences Announced Publication Of Real-world Study Of TriNav Device For Trans-arterial Chemoembolization And Trans-Arterial Radioembolization In Patients With Hepatocellular Carcinoma And Liver Metastases
Author: Benzinga Newsdesk | February 29, 2024 08:15am